Encompass Health Corporation reported its Q3 2022 results, demonstrating strong demand for inpatient rehabilitation services with a 7.5% increase in total discharges. However, elevated staffing costs impacted profitability, leading to a revision of the company's 2022 guidance.
Third quarter discharge growth was 7.5%, inclusive of 4.1% same-store growth.
The company made continued progress on reducing contract labor through hiring and retention initiatives.
Elevated staffing costs again impacted profitability.
The company has revised its 2022 guidance.
The Company is revising its guidance for full-year 2022. Net operating revenue is expected to be $4,320 to $4,350 million. Adjusted EBITDA is expected to be $800 to $820 million. Adjusted earnings per share from continuing operations attributable to Encompass Health is expected to be $2.71 to $2.86.